Pursuant to Rule 13a-16 or 15d-16 of the
04530-000 São Paulo, SP
Federative Republic of Brazil
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F _______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In March 2020:
( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)
( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
Company Name: Ambev S.A. |
| |||||||||
Name: Ambev Luxembourg S.À.R.L. | CPF/CNPJ: |
| ||||||||
Qualification: Position – Total Return Swap |
| |||||||||
Initial Balance |
| |||||||||
Securities / Derivatives | Securities Characteristics(2) | Quantity | ||||||||
Derivatives | Swap referenced in Shares | 30,039,800 |
| |||||||
Derivatives | Swap referenced in ADR | 26,974,653 |
| |||||||
Transactions in the month |
| |||||||||
Securities / Derivatives | Securities Characteristics(2) | Intermediary | Operation | Day | Quantity | Price | Volume(3) |
| ||
Derivatives | Swap referenced in Shares | Banco Bradesco | Total Return Swap Maturity | 19 | 1,411,700 | R$ 11.70 | R$ 16,516,890.00 |
| ||
Derivatives | Swap referenced in Shares | Banco Bradesco | Total Return Swap Conclusion | 19 | 1,411,700 | R$ 11.70 | R$ 16,516,890.00 |
| ||
Derivatives | Swap referenced in Shares | Banco Bradesco | Total Return Swap Maturity | 23 | 1,450,000 | R$ 11.51 | R$ 16,689,500.00 |
| ||
Derivatives | Swap referenced in Shares | Banco Bradesco | Total Return Swap Conclusion | 23 | 1,450,000 | R$ 11.51 | R$ 16,689,500.00 |
| ||
Final Balance |
| |||||||||
Securities / Derivatives | Securities Characteristics(2) | Quantity | ||||||||
Derivatives | Swap referenced in Shares | 30,039,800 |
| |||||||
Derivatives | Swap referenced in ADR | 26,974,653 |
| |||||||
|
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price.
(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.
INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In March 2020:
( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)
( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
Company Name: Ambev S.A. |
| ||||||||||
Name: Ambev S.A. | CPF/CNPJ: 07.526.557/0001-00 |
| |||||||||
Qualification: Outstanding Shares in Treasury |
| ||||||||||
Initial Balance |
| ||||||||||
Securities / Derivatives | Securities Characteristics (2) | Quantity | |||||||||
Shares | Common | 2,953,604 |
| ||||||||
Transactions in the month |
| ||||||||||
Securities / Derivatives | Securities Characteristics (2) | Intermediary | Operation | Day | Quantity | Price | Volume (3) |
| |||
Shares | Common | Direct with the Company | Conversion into ADR | 03 | 14,114 | R$ 0.00 | R$ 0.00 |
| |||
Shares | Common | Direct with the Company | Conversion into ADR | 19 | 3,234 | R$ 0.00 | R$ 0.00 |
| |||
Shares | Common | Direct with the Company | Conversion into ADR | 23 | 6,617 | R$ 0.00 | R$ 0.00 |
| |||
Shares | Common | Direct with the Company | Conversion into ADR | 30 | 33,658 | R$ 0.00 | R$ 0.00 |
| |||
|
|
| Total Conversion into ADR (Sell) |
| 57,623 |
| R$ 0.00 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 02 | 61,250 | R$ 1.77036 | R$ 108,434.55 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 03 | 52,850 | R$ 1.77036 | R$ 93,563.53 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 04 | 52,850 | R$ 1.77036 | R$ 93,563.53 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 04 | 36,150 | R$ 9.35960 | R$ 338,349.54 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 04 | 30,465 | R$ 11.97200 | R$ 364,726.98 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 06 | 32,200 | R$ 1.77036 | R$ 57,005.59 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 24 | 43,250 | R$ 1.77036 | R$ 76,568.07 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 25 | 87,500 | R$ 1.77036 | R$ 154,906.50 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 26 | 25,150 | R$ 6.95880 | R$ 175,013.82 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 26 | 55,200 | R$ 1.77036 | R$ 97,723.87 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 27 | 25,150 | R$ 1.77036 | R$ 44,524.55 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 29 | 43,250 | R$ 1.77036 | R$ 76,568.07 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 30 | 163,975 | R$ 1.77036 | R$ 290,294.78 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 30 | 105,700 | R$ 6.95880 | R$ 735,545.16 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 30 | 58,050 | R$ 7.47200 | R$ 433,749.60 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 30 | 39,135 | R$ 8.72400 | R$ 341,413.74 |
| |||
Shares | Common | Direct with the Company | Exerc Options | 30 | 40,395 | R$ 11.71000 | R$ 473,025.45 |
| |||
Shares | Common | Direct with the Company | Shares’ Bonus | 30 | 103,041 | R$ 14.54 | R$ 1,498,216.14 |
| |||
|
|
| Total Sell |
| 1,055,561 |
| R$ 5,453,193.47 |
| |||
Shares | Common | Direct with the Company | Plan of Shares Acquisition | 03 | 6,348 | R$ 14.74 | R$ 93,569.52 |
| |||
Shares | Common | Direct with the Company | Plan of Shares Acquisition | 04 | 52,034 | R$ 15.31 | R$ 796,640.54 |
| |||
Shares | Common | Direct with the Company | Plan of Shares Acquisition | 26 | 13,673 | R$ 12.80 | R$ 175,014.40 |
| |||
Shares | Common | Direct with the Company | Plan of Shares Acquisition | 30 | 119,421 | R$ 12.55 | R$ 1,498,733.55 |
| |||
|
|
| Total Buy |
| 191,476 |
| R$ 2,563,958.01 |
| |||
ADR | Common | Direct with the Company | Conversion into ADR | 03 | 14,114 | R$ 0.00 | R$ 0.00 |
| |||
ADR | Common | Direct with the Company | Conversion into ADR | 19 | 3,234 | R$ 0.00 | R$ 0.00 |
| |||
ADR | Common | Direct with the Company | Conversion into ADR | 23 | 6,617 | R$ 0.00 | R$ 0.00 |
| |||
ADR | Common | Direct with the Company | Conversion into ADR | 30 | 33,658 | R$ 0.00 | R$ 0.00 |
| |||
|
|
| Conversion into ADR (Buy) |
| 57,623 |
| R$ 0.00 |
| |||
ADR | Common | Direct with the Company | Plan of Shares Acquisition | 03 | 18,786 | R$ 14.7213968 | R$ 276,556.16 |
| |||
ADR | Common | Direct with the Company | Plan of Shares Acquisition | 19 | 12,966 | R$ 12.0378605 | R$ 156,082.90 |
| |||
ADR | Common | Direct with the Company | Plan of Shares Acquisition | 23 | 32,858 | R$ 11.4312317 | R$ 375,607.41 |
| |||
|
|
| Total Buy |
| 64,610 |
| R$ 808,246.47 |
| |||
ADR | Common | Direct with the Company | Exerc Options | 03 | 32,900 | R$ 8.4059623 | R$ 276,556.16 |
| |||
ADR | Common | Direct with the Company | Exerc Options | 19 | 16,200 | R$ 9.6347469 | R$ 156,082.90 |
| |||
ADR | Common | Direct with the Company | Exerc Options | 23 | 39,475 | R$ 9.5150705 | R$ 375,607.41 |
| |||
ADR | Common | Direct with the Company | ADR’s Bonus | 30 | 33,658 | R$ 14.54 | R$ 489,387.32 |
| |||
|
|
| Total Sell |
| 122,233 |
| R$ 1,297,633.79 |
| |||
Final Balance |
| ||||||||||
Securities / Derivatives | Securities Characteristics (2) | Quantity | |||||||||
Shares | Common | 2,031,896 |
| ||||||||
|
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price.
AMBEV S.A. | ||
By: | /s/Fernando Mommensohn Tennenbaum | |
Fernando Mommensohn Tennenbaum Chief Financial and Investor Relations Officer |